Lung Cancer Research Grant Opportunities

LCFA presents lung cancer research grant opportunities to researchers worldwide who present the “best in science” projects in the field. These annual lung cancer research grant awards are 6-figure grants, allowing the researcher to set up a lab, hire...

Immunotherapy for Lung Cancer Update

Within 2016, the FDA approved two immunotherapies – also called checkpoint inhibitors – for people with some forms of lung cancer whose cancer starts growing again after other treatment. In October, 2016, the FDA approved Tencentriq (atezolizumab) for second line...